Importantly, in Hao Li et al.'s research, they found that in diabetic cardiomyopathy, piceatannol alleviates inflammation and oxidative stress by activating the Nrf2/HO-1 pathway while inhibiting NF-κB activation in Rat H9C2 cardiac myoblasts. Here, HMOX1 is linked to diabetic cardiomyopathy.